17554 Holly Well Ave., Tampa, FL 33598
June 30, 2026 Herbalife reported its Q2 results recently. The company sells a significant amount of weight management products in the United States and North America. In July 2026, Herbalife launched Bioniq, their next generation of personalized products, as well as new products within our Life I/O portfolio in North America, which includes a protein-based […]
Herbalife Reports Q2 Results Read More »
June 30, 2026 Management reported Medifast Q2 results, as follows: Second Quarter 2026 • Revenue: $76.4 million, with revenue per active earning coach of $6,529 • Independent active earning coaches of 11,700 • Net loss of $3.1 million or $0.28 loss per diluted share (“EPS”) • Cash, Cash Equivalents, and Investment Securities of $169.8 million
Medifast Reports Q2 2026 Results Read More »
May 7, 2026 According to management: “We remain confident in our strategy to build the industry-leading weight health platform. Our focus is on executing high-impact initiatives that drive Clinical growth and stabilize our Behavioral business,” said Jon Volkmann, Chief Operations Officer and member of the Company’s Interim Office of the Chief Executive. “We made encouraging
Weight Watchers Reports Q1 2026 Results Read More »
May 6, 2026 Medifast reports its first quarter 2026 results. According to management: “We are encouraged by the continued progress we are seeing as we execute our metabolic health strategy, including a second consecutive quarter of year-over-year coach productivity growth, strong coach leadership advancement, and high field engagement. These are metrics that have historically been
Medifast Reports Q1 2026 Results Read More »
April 2, 2026 On April 1, 2026, the FDA approved Foundayo (orforglipron), a new once-daily oral GLP-1 weight loss pill developed by Eli Lilly for adults with obesity or overweight and at least one weight-related condition. Unlike other options, Foundayo does not require fasting or specific timing. It mimics a natural hormone to regulate appetite and,
New Eli Lilly Weight Loss Pill Approved – Foundayo Read More »
March 17, 2026 Weight Watchers reports its 2025 results yesterday. The firm’s revenues came in at $710 million, a 9.6% decline from 2024 revenues of $786 million. The company is expecting an 11% decrease in 2026 revenues, to between $620 and $635 million. 2025 Total Revenue and Adjusted EBITDA above high end of previously provided
Weight Watchers Reports Q4 & Full Year 2025 Results, 2026 Guidance Read More »
March 15, 2026 Medifast is an MLM (multilevel marketer) that sells meal replacements and diet foods, via health coaches. Their sales declined by 36% in 2025, to $386 million. Herbalife is another MLM that sells meal replacements and appetite suppressants, via health coaches. Their weight loss product sales in North America only declined by an
A Tale of Two MLM Competitors Read More »
March 12, 2026 The FDA is finally cracking down on telehealth companies marketing compounded weight loss drugs, warning them not to imply their products are FDA-approved or that they manufacture the medications. Roughly 30% of the more than 70 telehealth companies warned in the past six months rely on just four nationwide “white-label” medical groups
FDA Cracks Down on Telehealth Companies Read More »
March 4, 2026 Marketdata LLC has released a new report: “The U.S. Weight Loss Market: Status Report & 2026 Forecast” This 108-page analysis tracks the current status of ALL weight loss market segments, 2025 performance, the latest dieting trends, 15 competitor profiles, with 27 tables and charts. Some findings: The total U.S. weight loss market
U.S. Weight Loss Market Now Worth $135 Billion – New Report Read More »
Feb. 18, 2026 Medifast reported full-year and Q4 2025 results on February 17, 2026. 2025 revenues came in at $386 million – a 36% decrease from $602 million in 2024. The company employed 16,100 active earning Optavia health coaches, who had quarterly earnings of $4,664 (or $18,656 on an annual rate). “As we enter 2026,
Medifast Reports Q4 and Full Year 2025 Results Read More »